pfizer glp 1 agonist One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained China Opens Its Weight-Loss Drug

Methods We selected individuals aged 45 years and older already treated with metformin living in Lombardy, Italy, and then split them into two groups if they initiated GLP-1 RAs or other antidiabetic drugs, between 2019 and 2021

Two recent studies suggest that treating obesity and metabolic dysfunction with GLP-1 drugs could help restore hormonal balance and reproductive function in both women and men.

Fox News senior medical analyst Dr

In this review we summarize the results of recent cardiovascular outcome trials and discuss the potential clinical advantage of SGLT2 inhibitors and GLP-1 receptor agonists

Obesity is prevalent within the inflammatory bowel disease (IBD) population

These facts, together with increasing comorbidities in patients with IBD, imply that urgent, more complex, novel therapeutic strategies in the treatment are needed